Kegonsa Seed Fund

Kegonsa Seed Fund is a Wisconsin-based venture capital firm that specializes in seed-stage investments in high-growth startups, with a primary focus on the life sciences, biotechnology, and medical device sectors. Founded in 2004 by Ken Johnson, the fund is dedicated to commercializing innovations originating from regional research institutions, particularly the University of Wisconsin-Madison. The firm employs a disciplined investment strategy aimed at bridging the funding gap for early-stage companies to reach significant value-creation milestones. Notable portfolio successes include NeuWave Medical, which was acquired by Johnson & Johnson's Ethicon division, and FluGen, a developer of novel influenza vaccines. Kegonsa Seed Fund remains a pivotal institutional investor within the Midwest's healthcare and technology entrepreneurship ecosystem.